Several transcription factors were predicted to target genes enriched with hypermethylation across cancer types, including AHR-ARNT, ATF2 (CREBP1), PAX4, E2F2 and NRSF (Additional file2: Figure S6C). The gene discussed is REST; the disease is cancer.